GKB Ophthalmics Ltd
Incorporated in 1981, GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and Plastic
- Market Cap ₹ 59.1 Cr.
- Current Price ₹ 117
- High / Low ₹ 198 / 63.3
- Stock P/E 24.5
- Book Value ₹ 130
- Dividend Yield 0.00 %
- ROCE 4.64 %
- ROE 2.06 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.90 times its book value
- Debtor days have improved from 127 to 100 days.
Cons
- The company has delivered a poor sales growth of -1.48% over past five years.
- Company has a low return on equity of -0.16% over last 3 years.
- Contingent liabilities of Rs.19.3 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
38.74 | 42.80 | 41.45 | 35.18 | 43.76 | 76.44 | 77.93 | 57.16 | 58.53 | 56.88 | 70.94 | 72.99 | |
31.87 | 40.58 | 33.88 | 34.34 | 44.46 | 74.55 | 76.59 | 56.02 | 56.40 | 54.58 | 66.04 | 67.37 | |
Operating Profit | 6.87 | 2.22 | 7.57 | 0.84 | -0.70 | 1.89 | 1.34 | 1.14 | 2.13 | 2.30 | 4.90 | 5.62 |
OPM % | 17.73% | 5.19% | 18.26% | 2.39% | -1.60% | 2.47% | 1.72% | 1.99% | 3.64% | 4.04% | 6.91% | 7.70% |
0.70 | 0.63 | 1.09 | 1.13 | 11.72 | 3.78 | 0.49 | 2.30 | 1.11 | 1.94 | 1.20 | 0.94 | |
Interest | 2.67 | 2.88 | 2.86 | 2.50 | 1.63 | 1.29 | 1.27 | 1.48 | 1.46 | 2.03 | 1.48 | 1.65 |
Depreciation | 0.87 | 1.18 | 1.22 | 1.55 | 1.49 | 1.43 | 1.70 | 3.54 | 3.62 | 3.14 | 2.67 | 1.88 |
Profit before tax | 4.03 | -1.21 | 4.58 | -2.08 | 7.90 | 2.95 | -1.14 | -1.58 | -1.84 | -0.93 | 1.95 | 3.03 |
Tax % | 19.85% | 10.74% | 46.07% | 37.02% | 50.00% | 11.86% | 14.91% | 30.38% | 0.00% | 19.35% | 0.00% | |
Net Profit | 3.08 | -0.62 | 3.99 | 0.00 | 3.95 | 2.59 | -0.97 | -1.10 | -1.84 | -0.75 | 1.94 | 3.01 |
EPS in Rs | 7.42 | -1.49 | 9.61 | 0.00 | 9.51 | 6.24 | -2.34 | -2.37 | -3.65 | -1.81 | 2.52 | 4.79 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | -1% |
3 Years: | 7% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | -8% |
5 Years: | 26% |
3 Years: | 36% |
TTM: | -5% |
Stock Price CAGR | |
---|---|
10 Years: | 23% |
5 Years: | -6% |
3 Years: | 17% |
1 Year: | 47% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | -1% |
3 Years: | 0% |
Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.64 | 5.04 | 5.04 | 5.04 | 5.04 | |
Reserves | 31.12 | 30.81 | 35.74 | 35.86 | 40.66 | 42.63 | 40.79 | 47.26 | 54.21 | 57.61 | 58.06 | 60.44 |
13.64 | 15.09 | 12.51 | 8.62 | 7.22 | 7.19 | 9.93 | 14.07 | 15.16 | 11.97 | 11.76 | 11.58 | |
21.91 | 22.72 | 20.95 | 26.35 | 17.18 | 27.80 | 28.11 | 27.93 | 28.05 | 32.20 | 35.30 | 39.19 | |
Total Liabilities | 70.82 | 72.77 | 73.35 | 74.98 | 69.21 | 81.77 | 82.98 | 93.90 | 102.46 | 106.82 | 110.16 | 116.25 |
11.75 | 12.70 | 13.84 | 11.90 | 12.66 | 17.60 | 18.34 | 25.85 | 26.33 | 23.75 | 22.65 | 11.47 | |
CWIP | 2.68 | 2.29 | 0.57 | 0.57 | 0.57 | 0.57 | 0.24 | 0.00 | 0.00 | 1.23 | 3.41 | 3.95 |
Investments | 11.99 | 12.37 | 15.06 | 16.25 | 10.33 | 3.48 | 0.37 | 0.54 | 1.15 | 2.08 | 1.97 | 1.91 |
44.40 | 45.41 | 43.88 | 46.26 | 45.65 | 60.12 | 64.03 | 67.51 | 74.98 | 79.76 | 82.13 | 98.92 | |
Total Assets | 70.82 | 72.77 | 73.35 | 74.98 | 69.21 | 81.77 | 82.98 | 93.90 | 102.46 | 106.82 | 110.16 | 116.25 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|
3.31 | 3.29 | 6.45 | 7.23 | -11.44 | -3.41 | -2.66 | 3.92 | 3.27 | 6.86 | 5.07 | |
-4.98 | -1.52 | -1.96 | -0.50 | 14.68 | 3.75 | 1.34 | -9.89 | -3.73 | -16.78 | -3.52 | |
1.69 | -0.96 | -4.81 | -6.01 | -2.83 | -1.33 | 1.37 | 13.13 | 4.30 | 2.77 | -1.66 | |
Net Cash Flow | 0.02 | 0.81 | -0.32 | 0.72 | 0.40 | -0.99 | 0.04 | 7.16 | 3.84 | -7.15 | -0.12 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 176.85 | 157.17 | 185.01 | 190.70 | 142.63 | 118.04 | 128.61 | 150.32 | 155.40 | 125.00 | 100.38 |
Inventory Days | 448.52 | 362.01 | 344.73 | 423.86 | 284.87 | 225.01 | 223.44 | 289.19 | 301.35 | 348.75 | 306.81 |
Days Payable | 219.63 | 167.41 | 162.66 | 343.18 | 155.84 | 169.18 | 167.74 | 217.28 | 233.86 | 234.31 | 208.09 |
Cash Conversion Cycle | 405.74 | 351.78 | 367.08 | 271.38 | 271.67 | 173.87 | 184.32 | 222.23 | 222.89 | 239.45 | 199.10 |
Working Capital Days | 190.04 | 167.66 | 187.21 | 171.09 | 214.45 | 144.54 | 160.93 | 199.49 | 204.67 | 187.70 | 152.45 |
ROCE % | 5.17% | 13.68% | -0.18% | -1.45% | 3.32% | 0.22% | -2.55% | -0.56% | 2.83% | 4.64% |
Documents
Announcements
- Submission Of Consolidated Related Party Transactions As On March 31 2023. 38m
- Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On May 30 2023 - Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2023. 43m
- Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( LODR ) Regulations , 2015 3h
- Intimation Under Regulation 30 Of SEBI ( LODR) Regulations, 2015 - Resignation Of Internal Auditors Of The Company 3h
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
3h - CIR/CFD/CMD1/27/2019 dated February 08, 2019, issued by the SEBI, for the purpose of compliance with Regulation 24A of SEBI (LODR) Regulations 2015, enclosed please find …
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor
b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
c) Progressive: 1.498 CR-39, 1.50 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
d) Aspheric: 1.498 CR-39